Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000139

Director sold 1,666 shares at $20.66 ($34,420)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2023-10-16 Sale 10b5-1 −1,666 $20.66 $34,420 128,039 D: show line 1 in the form
Open-market sales · 1,666 sh · avg $20.66 · $34,420
Loading xslF345X05/wk-form4_1697661869.xml…